CASC
QTTB icon

Coppell Advisory Solutions Corp’s Q32 Bio QTTB Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$30 – 1125
2022
Q4 		$30 Buy
+1
New +$27 ﹤0.01% 1185

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Coppell Advisory Solutions Corp's QTTB Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of Q32 Bio (QTTB) in Q1 2023, closing a stake of 1 share — an estimated $30 sold.

Coppell Advisory Solutions Corp first reported a position in QTTB in Q4 2022 and held it in 1 quarter. The position peaked at $30 in Q4 2022. 62 funds tracked by Wall St. Rank hold QTTB as of Q1 2023.

  • Coppell Advisory Solutions Corp reported no remaining Q32 Bio position as of Q1 2023 after selling out during the quarter.
  • Coppell Advisory Solutions Corp sold 1 Q32 Bio share in Q1 2023, an estimated $30.
  • Coppell Advisory Solutions Corp first reported a position in Q32 Bio in Q4 2022 and held it in 1 quarter.
  • Coppell Advisory Solutions Corp's Q32 Bio position peaked at $30 in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.